GeekWire July 18, 2024
Gillian Dohrn

Bonum Therapeutics is moving into new offices near Seattle’s South Lake Union neighborhood and plans to double its headcount in pursuit of immunotherapy drugs. The biotech startup will occupy the 11th floor of the Alexandria’s new life science tower at 1150 Eastlake Ave. E.

“We’re very excited about 1150,” said CEO John Mulligan. “It’s beautiful, great views. It’ll be a really fun space.”

Mulligan said Bonum discovered the vacancy during the biotech downturn in 2022. The Alexandria building is in an area of Seattle that’s home to multiple biotech startups and life science research organizations, such as Fred Hutchinson Cancer Research and The Allen Institute.

Bonum will move in August from its current offices in the nearby Access...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article